KR970000222A - 팩리택셀 유도체의 전구약물 - Google Patents
팩리택셀 유도체의 전구약물Info
- Publication number
- KR970000222A KR970000222A KR1019960019825A KR19960019825A KR970000222A KR 970000222 A KR970000222 A KR 970000222A KR 1019960019825 A KR1019960019825 A KR 1019960019825A KR 19960019825 A KR19960019825 A KR 19960019825A KR 970000222 A KR970000222 A KR 970000222A
- Authority
- KR
- South Korea
- Prior art keywords
- patricaxel
- prodrugs
- derivatives
- patricaxel derivatives
- Prior art date
Links
- 229940002612 prodrug Drugs 0.000 title 1
- 239000000651 prodrug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6551—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring
- C07F9/65512—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46924795A | 1995-06-06 | 1995-06-06 | |
US469,247 | 1995-06-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR970000222A true KR970000222A (ko) | 1997-01-21 |
KR100375956B1 KR100375956B1 (ko) | 2003-04-21 |
Family
ID=23863053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960019825A KR100375956B1 (ko) | 1995-06-06 | 1996-06-04 | 팩리택셀유도체의전구약물 |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0747385B1 (ko) |
JP (1) | JPH08337589A (ko) |
KR (1) | KR100375956B1 (ko) |
CN (1) | CN1066151C (ko) |
AR (1) | AR002756A1 (ko) |
AT (1) | ATE222259T1 (ko) |
AU (1) | AU695959B2 (ko) |
CA (1) | CA2176191A1 (ko) |
CZ (1) | CZ291516B6 (ko) |
DE (1) | DE69622933T2 (ko) |
DK (1) | DK0747385T3 (ko) |
ES (1) | ES2181824T3 (ko) |
HU (1) | HUP9601524A3 (ko) |
IL (1) | IL118526A (ko) |
MX (1) | MX9601994A (ko) |
NO (1) | NO315233B1 (ko) |
NZ (1) | NZ286723A (ko) |
PL (1) | PL187883B1 (ko) |
PT (1) | PT747385E (ko) |
RU (1) | RU2162082C2 (ko) |
SG (1) | SG72692A1 (ko) |
TW (1) | TW354293B (ko) |
ZA (1) | ZA964261B (ko) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6395770B1 (en) * | 1995-10-26 | 2002-05-28 | Baker Norton Pharmaceuticals, Inc. | Method and compositions for administering taxanes orally to human patients |
US6495579B1 (en) | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
US6515016B2 (en) | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
RU2205005C2 (ru) * | 1997-05-27 | 2003-05-27 | Бейкер Нортон Фармасьютикалз, Инк. | Способ и композиции для перорального введения таксанов пациентам |
US6204257B1 (en) * | 1998-08-07 | 2001-03-20 | Universtiy Of Kansas | Water soluble prodrugs of hindered alcohols |
AU776511B2 (en) * | 1999-02-18 | 2004-09-09 | Baylor University | Compositions and methods for use in targeting vascular destruction |
US6362172B2 (en) * | 2000-01-20 | 2002-03-26 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
AR030188A1 (es) | 2000-02-02 | 2003-08-13 | Univ Florida State Res Found | Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos |
CN1362958A (zh) | 2000-02-02 | 2002-08-07 | 佛罗里达州立大学研究基金有限公司 | 用作抗肿瘤剂的c7碳酸酯取代的紫杉烷 |
US6916942B2 (en) | 2000-02-03 | 2005-07-12 | Bristol-Myers Squibb Company | Process for the preparation of C-4 carbonate taxanes |
US6750246B1 (en) | 2000-02-03 | 2004-06-15 | Bristol-Myers Squibb Company | C-4 carbonate taxanes |
US7063977B2 (en) | 2001-08-21 | 2006-06-20 | Bristol-Myers Squibb Company | Enzymatic resolution of t-butyl taxane derivatives |
KR20030049023A (ko) * | 2001-12-13 | 2003-06-25 | 주식회사 코오롱 | 방사선 감작제용 파클리탁셀 유도체 |
TW200540164A (en) | 2004-03-05 | 2005-12-16 | Univ Florida State Res Found | C7 lactyloxy-substituted taxanes |
CN105879114A (zh) * | 2005-02-18 | 2016-08-24 | 阿布拉西斯生物科学公司 | 用于整合入医疗装置的疏水性改善的药物 |
JP2016512831A (ja) | 2013-03-15 | 2016-05-09 | コンサート ファーマシューティカルズ インコーポレイテッド | 重水素化されたパルボシクリブ |
WO2015009889A1 (en) | 2013-07-18 | 2015-01-22 | Concert Pharmaceuticals, Inc. | Deuterated intedanib derivatives and their use for the treatment of proliferative disorders |
SG10202112588PA (en) * | 2015-11-19 | 2021-12-30 | Biohaven Pharm Holding Co Ltd | Amine prodrugs of pharmaceutical compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2111527C (en) * | 1992-12-24 | 2000-07-18 | Jerzy Golik | Phosphonooxymethyl ethers of taxane derivatives |
CA2129288C (en) * | 1993-08-17 | 2000-05-16 | Jerzy Golik | Phosphonooxymethyl esters of taxane derivatives |
-
1996
- 1996-04-27 TW TW085105043A patent/TW354293B/zh active
- 1996-05-09 CA CA002176191A patent/CA2176191A1/en not_active Abandoned
- 1996-05-27 MX MX9601994A patent/MX9601994A/es not_active IP Right Cessation
- 1996-05-27 ZA ZA9604261A patent/ZA964261B/xx unknown
- 1996-05-29 CZ CZ19961563A patent/CZ291516B6/cs not_active IP Right Cessation
- 1996-05-31 NO NO19962231A patent/NO315233B1/no not_active Application Discontinuation
- 1996-06-02 IL IL11852696A patent/IL118526A/en not_active IP Right Cessation
- 1996-06-03 JP JP8139795A patent/JPH08337589A/ja active Pending
- 1996-06-03 AR ARP960102865A patent/AR002756A1/es active IP Right Grant
- 1996-06-04 KR KR1019960019825A patent/KR100375956B1/ko not_active IP Right Cessation
- 1996-06-04 NZ NZ286723A patent/NZ286723A/en unknown
- 1996-06-05 DE DE69622933T patent/DE69622933T2/de not_active Expired - Fee Related
- 1996-06-05 RU RU96111012/04A patent/RU2162082C2/ru not_active IP Right Cessation
- 1996-06-05 HU HU9601524A patent/HUP9601524A3/hu unknown
- 1996-06-05 DK DK96109044T patent/DK0747385T3/da active
- 1996-06-05 EP EP96109044A patent/EP0747385B1/en not_active Expired - Lifetime
- 1996-06-05 AT AT96109044T patent/ATE222259T1/de not_active IP Right Cessation
- 1996-06-05 AU AU54718/96A patent/AU695959B2/en not_active Ceased
- 1996-06-05 PT PT96109044T patent/PT747385E/pt unknown
- 1996-06-05 PL PL31463796A patent/PL187883B1/pl not_active IP Right Cessation
- 1996-06-05 ES ES96109044T patent/ES2181824T3/es not_active Expired - Lifetime
- 1996-06-06 SG SG1996009989A patent/SG72692A1/en unknown
- 1996-06-06 CN CN96106851A patent/CN1066151C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE222259T1 (de) | 2002-08-15 |
PT747385E (pt) | 2002-11-29 |
TW354293B (en) | 1999-03-11 |
IL118526A (en) | 2001-05-20 |
SG72692A1 (en) | 2000-05-23 |
ES2181824T3 (es) | 2003-03-01 |
RU2162082C2 (ru) | 2001-01-20 |
HU9601524D0 (en) | 1996-07-29 |
PL314637A1 (en) | 1996-12-09 |
HUP9601524A3 (en) | 2000-03-28 |
AU5471896A (en) | 1996-12-19 |
DE69622933D1 (de) | 2002-09-19 |
KR100375956B1 (ko) | 2003-04-21 |
CN1066151C (zh) | 2001-05-23 |
CZ291516B6 (cs) | 2003-03-12 |
AR002756A1 (es) | 1998-04-29 |
DE69622933T2 (de) | 2003-04-24 |
NZ286723A (en) | 1998-03-25 |
NO315233B1 (no) | 2003-08-04 |
MX9601994A (es) | 1997-08-30 |
CZ156396A3 (en) | 1996-12-11 |
IL118526A0 (en) | 1996-10-16 |
NO962231D0 (no) | 1996-05-31 |
DK0747385T3 (da) | 2002-12-16 |
EP0747385B1 (en) | 2002-08-14 |
HUP9601524A2 (en) | 1997-05-28 |
EP0747385A1 (en) | 1996-12-11 |
PL187883B1 (pl) | 2004-10-29 |
CN1144805A (zh) | 1997-03-12 |
CA2176191A1 (en) | 1996-12-07 |
NO962231L (no) | 1996-12-09 |
ZA964261B (en) | 1997-11-27 |
AU695959B2 (en) | 1998-08-27 |
JPH08337589A (ja) | 1996-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9611130A (pt) | Derivados de 3-aril-5-halógeno-pirona | |
DE69522717D1 (de) | Chinazolinderivate | |
DE69611361D1 (de) | Chinazolin-derivate | |
NO974103D0 (no) | Arylsulfonylaminohydroksamsyre-derivater | |
DE69610698D1 (de) | Chinazolin-derivate | |
BR9507179A (pt) | Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena | |
PT833828E (pt) | Derivados de rapamicina | |
BR9611834A (pt) | Derivados de oximetóxi-3-aril-pirona | |
NO964667D0 (no) | Purin-6-on-derivater | |
ATE199150T1 (de) | Diphenylmethylenpiperidin-derivate | |
KR970000222A (ko) | 팩리택셀 유도체의 전구약물 | |
DE69601527D1 (de) | Pyrrolylbenzimidazol-Derivate | |
ATA100695A (de) | Prothrombin-derivate | |
PT856007E (pt) | Derivados de ciclopeptidos | |
DE69628200D1 (de) | Diarylalkenylamin-derivate | |
DE69627830D1 (de) | Pyrazol-derivate | |
BR9607046A (pt) | Derivados de 3-pirrolidiliden-2-ona-cefalosporinas | |
DE59607054D1 (de) | 4-Amino-benzoylguanidin-Derivate | |
DE59610106D1 (de) | Fluorbenzylether-Derivate | |
ATE177102T1 (de) | Chromanderivate | |
BR9609723A (pt) | Derivados da tricetona | |
DK0843675T3 (da) | Aza-anthracyclinonderivater | |
BR9603508A (pt) | Derivados de alquenil-benzoilguanidina | |
ATE202088T1 (de) | 4-mercapto-benzoylguanidin-derivate | |
DE69620514D1 (de) | 5-aminoflavon-derivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20060223 Year of fee payment: 4 |
|
LAPS | Lapse due to unpaid annual fee |